| 1 |
ResMed Inc
RMD · États-Unis
|
$31B |
99/100
Élite
|
51/100 |
20.4%low 15.3% |
10 yr+ |
Net cash |
58% |
ResMed: A Long-Term Owner's Perspective28 mai 2026 · Watch |
FY2025 |
| 2 |
Cadence Design Systems Inc
CDNS · États-Unis
|
$94B |
97/100
Élite
|
51/100 |
27.5%low 20.3% |
10 yr+ |
Net cash |
88% |
Cadence Design Systems: A Deep Value Investing Analysis21 mai 2026 · Watch |
FY2025 |
| 3 |
Check Point Software Technologies Ltd
CHKP · États-Unis
|
$13B |
97/100
Élite
|
42/100 |
26.1%low 20.8% |
10 yr+ |
Net cash |
88% |
Check Point: A High-Margin Cash Engine Whose Growth Gap Is Not Yet in the Price16 août 2026 · Watch |
FY2025 |
| 4 |
Adobe Systems Incorporated
ADBE · États-Unis
|
$100B |
96/100
Élite
|
48/100 |
33.0%low 15.7% |
10 yr+ |
0.0× |
87% |
Adobe Investment Research from a Long-Term Business Owner's Perspective21 mai 2026 · Cautious Buy |
FY2025 |
| 5 |
Monster Beverage Corp
MNST · États-Unis
|
$94B |
96/100
Élite
|
49/100 |
23.0%low 17.0% |
10 yr+ |
Net cash |
58% |
Deep Value Investment Analysis of Monster Beverage Corporation22 mai 2026 · Watch |
FY2025 |
| 6 |
F5 Networks Inc
FFIV · États-Unis
|
$23B |
96/100
Élite
|
45/100 |
21.7%low 13.0% |
10 yr+ |
Net cash |
82% |
F5 Deep Value Investment Research29 mai 2026 · Watch |
FY2025 |
| 7 |
Garmin Ltd
GRMN · États-Unis
|
$57B |
95/100
Élite
|
47/100 |
17.6%low 14.9% |
10 yr+ |
Net cash |
58% |
Garmin Ltd. Deep Value Investment Research27 mai 2026 · Watch |
FY2025 |
| 8 |
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
300760 · Shenzhen
|
$27B |
95/100
Élite
|
52/100 |
30.1%low 21.4% |
10 yr+ |
Net cash |
64% |
Mindray Bio-Medical: The Transition Is Real, But So Is the Price Tag19 juillet 2026 · Hold |
FY2025 |
| 9 |
Snap-On Inc
SNA · États-Unis
|
$21B |
95/100
Élite
|
45/100 |
19.5%low 16.4% |
10 yr+ |
Net cash |
50% |
Snap-on Deep Value Investment Research30 mai 2026 · Watch |
FY2025 |
| 10 |
Manhattan Associates Inc
MANH · États-Unis
|
$11B |
95/100
Élite
|
53/100 |
56.1%low 39.9% |
10 yr+ |
Net cash |
54% |
Manhattan Associates: 26% Cloud Growth Sits Inside 9.3% Total Revenue Growth, Existing Customers Supplied 75% of Q2 New Cloud Contract Value, and 40x SBC-Adjusted Owner Earnings Leaves No Margin of Safety16 août 2026 · Hold |
FY2025 |
| 11 |
Jack Henry & Associates Inc
JKHY · États-Unis
|
$11B |
95/100
Élite
|
45/100 |
21.7%low 15.4% |
10 yr+ |
Net cash |
42% |
Jack Henry & Associates Deep Value Investment Analysis31 mai 2026 · Watch |
FY2025 |
| 12 |
Automatic Data Processing Inc
ADP · États-Unis
|
$106B |
94/100
Élite
|
48/100 |
52.2%low 42.5% |
10 yr+ |
0.2× |
47% |
ADP Long-Term Owner-Oriented Value Analysis21 mai 2026 · Watch |
FY2026 |
| 13 |
Intuit Inc
INTU · États-Unis
|
$86B |
94/100
Élite
|
50/100 |
33.7%low 12.6% |
10 yr+ |
0.1× |
82% |
Intuit Inc. Deep Value Analysis22 mai 2026 · Watch |
FY2025 |
| 14 |
Fastenal Company
FAST · États-Unis
|
$55B |
94/100
Élite
|
45/100 |
31.0%low 25.8% |
10 yr+ |
0.0× |
47% |
Fastenal Company: An In-Depth Value Study22 mai 2026 · Watch |
FY2025 |
| 15 |
Hansoh Pharmaceutical Group Co Ltd
3692 · Hong Kong
|
$25B |
94/100
Élite
|
53/100 |
26.3%low 11.4% |
10 yr+ |
Net cash |
91% |
Hansoh Pharmaceutical: One Molecule, One Royalty Book, and a Price That Already Pays for Both17 août 2026 · Hold |
FY2025 |
| 16 |
Hermes International SCA
RMS · Paris
|
$173B |
93/100
Élite
|
52/100 |
24.9%low 18.8% |
10 yr+ |
Net cash |
68% |
Hermès International SCA: A 41% Operating Margin Meets 6.1% Constant-Currency Growth, and EUR 1,475 Sits 18-31% Above the Conservative Value8 septembre 2026 · Hold |
FY2025 |
| 17 |
Accenture plc
ACN · États-Unis
|
$102B |
93/100
Élite
|
47/100 |
33.4%low 24.6% |
10 yr+ |
Net cash |
31% |
Accenture Research from a Long-Term Owner's Perspective23 mai 2026 · Cautious Buy |
FY2025 |
| 18 |
Infosys Ltd ADR
INFY · États-Unis
|
$51B |
93/100
Élite
|
42/100 |
27.5%low 20.1% |
10 yr+ |
Net cash |
33% |
Infosys: In-Depth Value Investing Research20 mai 2026 · Watch |
FY2026 |
| 19 |
Corpay Inc
CPAY · États-Unis
|
$25B |
93/100
Élite
|
52/100 |
26.1%low 14.7% |
10 yr+ |
0.3× |
78% |
Corpay: A Value Investing Deep Dive29 mai 2026 · Watch |
FY2025 |
| 20 |
NetEase Inc
NTES · États-Unis
|
$85B |
92/100
Élite
|
50/100 |
21.6%low 13.4% |
10 yr+ |
Net cash |
57% |
Analyse approfondie de NetEase, Inc.15 juin 2026 · Conserver |
FY2025 |
| 21 |
NetEase Inc
9999 · Hong Kong
|
$85B |
92/100
Élite
|
— |
22.0%low 13.6% |
10 yr+ |
Net cash |
57% |
— |
FY2025 |
| 22 |
Nike Inc
NKE · États-Unis
|
$62B |
92/100
Élite
|
43/100 |
33.5%low 19.7% |
10 yr+ |
0.1× |
44% |
NIKE In-Depth Value Investing Analysis26 mai 2026 · Watch |
FY2026 |
| 23 |
Deutsche Börse AG
DB1 · XETRA
|
$51B |
92/100
Élite
|
— |
18.7%low 16.8% |
10 yr+ |
Net cash |
59% |
— |
FY2025 |
| 24 |
IDEXX Laboratories Inc
IDXX · États-Unis
|
$44B |
92/100
Élite
|
47/100 |
58.9%low 55.7% |
10 yr+ |
0.6× |
58% |
In-Depth Value Research on IDEXX Laboratories22 mai 2026 · Watch |
FY2025 |
| 25 |
Foshan Haitian Flavouring and Food Co Ltd
603288 · Shanghai
|
$31B |
92/100
Élite
|
— |
26.3%low 17.0% |
10 yr+ |
Net cash |
41% |
— |
FY2025 |
| 26 |
ANTA Sports Products Ltd
2020 · Hong Kong
|
$28B |
92/100
Élite
|
55/100 |
23.7%low 19.9% |
10 yr+ |
Net cash |
57% |
ANTA Sports: Other Brands Grew 59.2% While the Core Brand Managed 3.7%, and at HKD 74.50 the Shares Already Sit Above the HKD 68 Conservative Sum-of-the-Parts7 août 2026 · Hold |
FY2025 |
| 27 |
Lululemon Athletica Inc.
LULU · États-Unis
|
$13B |
92/100
Élite
|
46/100 |
30.2%low 16.2% |
10 yr+ |
Net cash |
56% |
Lululemon Athletica Deep Value Investment Research30 mai 2026 · Watch |
FY2026 |
| 28 |
Brown-Forman Corporation
BF-B · États-Unis
|
$13B |
92/100
Élite
|
44/100 |
35.3%low 17.8% |
10 yr+ |
0.5× |
62% |
Brown-Forman Deep Value Analysis31 mai 2026 · Watch |
FY2026 |
| 29 |
SEI Investments Company
SEIC · États-Unis
|
$12B |
92/100
Élite
|
— |
27.0%low 21.7% |
10 yr+ |
Net cash |
60% |
— |
FY2025 |
| 30 |
Edwards Lifesciences Corp
EW · États-Unis
|
$50B |
91/100
Élite
|
48/100 |
23.4%low 10.4% |
10 yr+ |
Net cash |
76% |
Edwards Lifesciences In-Depth Value Research27 mai 2026 · Watch |
FY2025 |
| 31 |
Paychex Inc
PAYX · États-Unis
|
$42B |
91/100
Élite
|
46/100 |
42.6%low 37.2% |
10 yr+ |
0.9× |
71% |
Paychex Investment Research Report22 mai 2026 · Watch |
FY2026 |
| 32 |
Adyen NV
ADYEN · Amsterdam
|
$30B |
91/100
Élite
|
— |
23.4%low 18.3% |
10 yr+ |
Net cash |
72% |
— |
FY2025 |
| 33 |
Copart Inc
CPRT · États-Unis
|
$27B |
91/100
Élite
|
49/100 |
26.4%low 16.9% |
10 yr+ |
Net cash |
45% |
Copart Deep Value Investment Analysis21 mai 2026 · Watch |
FY2025 |
| 34 |
Gongniu Group Co Ltd
603195 · Shanghai
|
$11B |
91/100
Élite
|
— |
36.5%low 24.2% |
10 yr+ |
Net cash |
41% |
— |
FY2025 |
| 35 |
Cintas Corporation
CTAS · États-Unis
|
$82B |
90/100
Élite
|
46/100 |
32.2%low 20.9% |
10 yr+ |
0.5× |
47% |
Cintas Corporation Long-Term Owner's Perspective Research22 mai 2026 · Watch |
FY2026 |
| 36 |
Electronic Arts Inc
EA · États-Unis
|
$53B |
90/100
Élite
|
42/100 |
18.6%low 10.3% |
10 yr+ |
Net cash |
76% |
Electronic Arts: A Value-Investing Deep Dive22 mai 2026 · Watch |
FY2026 |
| 37 |
Mettler-Toledo International Inc
MTD · États-Unis
|
$29B |
90/100
Élite
|
45/100 |
60.0%low 60.0% |
10 yr+ |
— |
57% |
Mettler-Toledo International Inc.: A Value Investing Deep Dive29 mai 2026 · Watch |
FY2025 |
| 38 |
Evercore Partners Inc
EVR · États-Unis
|
$12B |
90/100
Élite
|
— |
28.4%low 13.7% |
10 yr+ |
Net cash |
99% |
— |
FY2025 |
| 39 |
Orion Oyj B
ORNBV · HE
|
$12B |
90/100
Élite
|
— |
33.1%low 24.4% |
10 yr+ |
0.1× |
60% |
— |
FY2025 |